Fingerprint
Dive into the research topics of 'Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial
Larry B. Goldstein, Pierre Amarenco, Justin Zivin, Michael Messig, Irfan Altafullah, Alfred Callahan, Michael Hennerici, Mary J. MacLeod, Henrik Sillesen, Richard Zweiffler, K. Michael, A. Welch, SPARCL Investigators
Research output: Contribution to journal › Article › peer-review
111
Citations
(Scopus)